Skip to main content
Premium Trial:

Request an Annual Quote

Singlera Genomics Closes $150M Series B Financing Round

NEW YORK — Singlera Genomics said on Tuesday that it has raised $150 million in a Series B financing round.

The round was led by CICC Kai Tak Innovative Biomedicine Fund and co-led by Detong Capital and Furong Investment. New investors include Huamei International, Linden Asset Group, Wuxi Capital, FutureX Skyline Capital, and Shanghai Free Trade Zone Fund. Existing investors participating in the financing include Greenpine Capital, Prosperico Ventures, and Proxima Ventures.

Singlera said it will use the new funding to expand its research and development of new early cancer screening products, to support regulatory and commercialization activities, and to expand prospective studies into pan-cancer early screening.

This summer, Singlera and collaborators at Fudan University published data showing that the company's circulating tumor DNA methylation multi-cancer screening technology, called PanSeer, could help detect cancer in asymptomatic people who were later diagnosed with cancer.

While La Jolla, California-based Singlera, which also has operations in Shanghai, is initially focusing on colorectal cancer detection with the PanSeer technology, it aims to expand to a pan-cancer setting in the future.

"We have developed early cancer screening and diagnostic technologies and products covering a variety of cancer types including lung, colorectal, liver, stomach, esophageal, pancreatic, and thyroid," Singlera Cofounder and scientific advisor Yuan Gao said in a statement. "This round of financing will help us carry out large-scale prospective studies and clinical trials."

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.